Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (381-390 of 560) with videos related to

Pageof 56
Sort By:
Autophagy|January 3, 2024
DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomasGamze Bildik, Joshua P Gray, Weiqun Mao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2016
Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian CancerArchana R Simmons, Charlotte H Clarke, Donna B Badgwell, et al.
Human Molecular Genetics|July 23, 2003
Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylationSatoshi Fujii, Robert Z Luo, Jiuhong Yuan, et al.
Progress in Clinical and Biological Research|January 1, 1990
Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantationE J Shpall, I C Anderson, R C Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical OncologyR C Bast, P Ravdin, D F Hayes, et al.
Gynecologic Oncology|August 3, 2005
Potential markers that complement expression of CA125 in epithelial ovarian cancerDaniel G Rosen, Lin Wang, J Neeley Atkinson, et al.
Nature|August 18, 1994
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitorG M McGeehan, J D Becherer, R C Bast, et al.
Cancer Biology & Therapy|August 17, 2012
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3Siqing Fu, Yanfang Li, Jie Huang, et al.
Annals of the New York Academy of Sciences|May 2, 2003
Epigenetic regulation of ARHI in breast and ovarian cancer cellsYinhua Yu, Satoshi Fujii, Jiuhong Yuan, et al.
Differentiation; Research in Biological Diversity|July 19, 2008
MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouseYing Wang, Dong-Joo Cheon, Zhen Lu, et al.
Pageof 56

Showing results (381-390 of 560) with videos related to

Sort By:
Pageof 56
Autophagy|January 3, 2024
DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomasGamze Bildik, Joshua P Gray, Weiqun Mao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2016
Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian CancerArchana R Simmons, Charlotte H Clarke, Donna B Badgwell, et al.
Human Molecular Genetics|July 23, 2003
Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylationSatoshi Fujii, Robert Z Luo, Jiuhong Yuan, et al.
Progress in Clinical and Biological Research|January 1, 1990
Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantationE J Shpall, I C Anderson, R C Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical OncologyR C Bast, P Ravdin, D F Hayes, et al.
Gynecologic Oncology|August 3, 2005
Potential markers that complement expression of CA125 in epithelial ovarian cancerDaniel G Rosen, Lin Wang, J Neeley Atkinson, et al.
Nature|August 18, 1994
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitorG M McGeehan, J D Becherer, R C Bast, et al.
Cancer Biology & Therapy|August 17, 2012
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3Siqing Fu, Yanfang Li, Jie Huang, et al.
Annals of the New York Academy of Sciences|May 2, 2003
Epigenetic regulation of ARHI in breast and ovarian cancer cellsYinhua Yu, Satoshi Fujii, Jiuhong Yuan, et al.
Differentiation; Research in Biological Diversity|July 19, 2008
MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouseYing Wang, Dong-Joo Cheon, Zhen Lu, et al.
Pageof 56